Mechanisms underlying obesity-associated reproductive impairment are ill defined. Hyperinsulinemia is a metabolic perturbation often observed in obese subjects. Insulin activates phosphatidylinositol 3-kinase (PI3K) signaling, which regulates ovarian folliculogenesis, steroidogenesis, and xenobiotic metabolism. The impact of progressive obesity on ovarian genes encoding mRNA involved in insulin-mediated PI3K signaling and xenobiotic biotransformation [insulin receptor (Insr), insulin receptor substrate 1 (Irs1), 2 (Irs2), and 3 (Irs3); kit ligand (Kitlg), stem cell growth factor receptor (Kit), protein kinase B (AKT) alpha (Akt1), beta (Akt2), forkhead transcription factor (FOXO) subfamily 1 (Foxo1), and subfamily 3 (Foxo3a), microsomal epoxide hydrolase (Ephx1), cytochrome P450 family 2, subfamily E, polypeptide 1 (Cyp2e1), glutathione S-transferase (GST) class Pi (Gstp1) and class mu 1 (Gstm1)] was determined in normal wild-type nonagouti (a/a; lean) and lethal yellow mice (KK.CG-A y/ J; obese) at 6, 12, 18, or 24 weeks of age. At 6 weeks, ovaries from obese mice had increased (P < 0.05) Insr and Irs3 but decreased (P < 0.05) Kitlg, Foxo1, and Cyp2e1 mRNA levels. Interestingly, at 12 weeks, an increase (P < 0.05) in Kitlg and Kit mRNA, pIRS1
Introduction
The adverse effects of obesity on reproductive health have been documented, and include reduced conception and implantation [1, 2] , impaired fecundity [2] [3] [4] [5] , increased infertility [1, 6] , and an increase in offspring birth defects [7] [8] [9] . Obesity affects approximately 30% of US adults, with higher levels observed in African American (∼48%) and Hispanic (∼43%) populations [10] . The same pattern is true in children, with approximately 17% being obese, and there are differential obesity rates in African American (∼20%) and Hispanic (∼22%) children. Thus, obesity affects all communities, but some are more affected than others. The adverse effects of obesity on reproductive health have been documented, and include reduced conception and implantation [29, 30] , impaired fecundity [30] [31] [32] [33] , and infertility [29, 34] . Obese mothers have increased risk for miscarriage [35] , poor oocyte quality [36] , and birth defects in their offspring [35] . It is also recognized that increased body mass index is a risk factor for many cancers, including ovarian cancer [37] . Mortality rates from ovarian cancer are greater in overweight and obese, relative to lean, women [38] and are also higher in African American relative to Caucasian women [39] . Furthermore, although studies are limited, a recent report positively associated human offspring cancer incidence with maternal obesity [40] .
The mammalian ovary is the female gonad responsible for oocyte and steroid hormone production. At birth, a finite number of primordial follicles are present, arrested in the diplotene stage of prophase 1 [11] . Once primordial follicles are depleted, the female enters into ovarian senescence. A number of chemical exposures can result in follicle depletion leading to early ovarian senescence [12] [13] [14] [15] [16] . In addition, DNA damage [17] and altered folliculogenesis [18] due to ovotoxicant exposure have been reported. The ovary has the capacity to respond to such exposures through increased abundance of proteins involved in chemical biotransformation, including cytochrome P450 isoform 2E1 (Cyp2e1) [19] [20] [21] , microsomal epoxide hydrolase (Ephx1) [22, 23] , glutathione S-transferase Pi (Gstp1) [15, 24] , and glutathione S-transferase Mu 1 (Gstm1) [25] . These enzymes are principally involved in the detoxification of xenobiotic compounds; however, their expression may also lead to bioactivation of some environmental compounds [12, 13, 19, 20, 26, 27] .
The phosphatidylinositol-3 kinase (PI3K) signaling pathway plays a pivotal role in regulating ovarian folliculogenesis [28] [29] [30] [31] and steroidogenesis [32] [33] [34] [35] . We [36] and others [37] [38] [39] [40] have demonstrated that obesity alters insulin-mediated signaling pathways, including PI3K. In addition, we have determined that PI3K signaling regulates abundance of the xenobiotic metabolism enzymes Gstp1, Gstm1, Ephx1, and Cyp2e1 [18, [41] [42] [43] . Altered expression of genes involved in these pathways could sabotage proper ovarian function and consequently lead to impaired fertility. Adverse reproductive outcomes including anovulation, impaired fecundity, and premature ovarian failure can result from unregulated folliculogenesis. In the absence of ovarian function, females have a greater risk for development of gynecological cancers, osteoporosis, and cardiovascular disease [16, 27, 44] . We have demonstrated that obese female mice have reduced numbers of preantral follicles, relative to their lean counterparts [45] ; however, the mechanisms involved remain unclear.
Despite a strong positive correlation between obesity and impaired reproductive capacity, the underlying mechanisms have not been clearly defined. To understand the onset and duration of changes in PI3K and chemical metabolism gene during obesity, we designed a study using the agouti lethal yellow (KK.Cg-Ay/J) mice, an excellent model for progressive obesity [46] [47] [48] . The impact of obesity onset and progression on expression of ovarian genes encoding insulin signaling, PI3K pathway members, and enzymes involved in ovarian xenobiotic biotransformation were investigated. Additionally, we challenged both lean and obese mice with the ovotoxicant, phosphoramide mustard (PM; the ovotoxic metabolite of cyclophosphamide [CPA]), and evaluated the response of EPHX1 to PM exposure in ovarian and lung tissue.
Materials and methods

Reagents
Phosphoramide mustard was obtained from the National Institutes of Health National Cancer Institute (Bethesda, MA). D-Glucose, 2-beta-mercaptoethanol, 30% acrylamide/0.8% bis-acrylamide, ammonium persulfate, glycerol, N ,N ,N ,NTetramethyl-ethylenediamine, Tris base, Tris HCl, sodium chloride, Tween-20, bovine serum albumin (BSA), ascorbic acid (vitamin C), phosphatase inhibitor, protease inhibitor, and transferrin were purchased from Sigma-Aldrich Inc. (St. Louis, MO). Custom designed primers were obtained from the DNA facility of the Office of Biotechnology at Iowa State University. Hanks balanced salt solution (without CaCl 2 , MgCl 2 , or MgSO 4 ) and superscript III one-step real-time polymerase chain reaction (RT-PCR) System were purchased from Invitrogen Co. (Carlsbad, CA). RNAlater was obtained from Ambion Inc. (Austin, TX). RNeasy Mini kit, QIAshredder kit, RNeasy MinElute kit, and QuantiTect SYBR Green PCR kit were purchased from Qiagen Inc. (Valencia, CA). Ponceau S was purchased from Fisher Scientific (Waltham, MA). Restore PLUS Western Blot Stripping Buffer was purchased from Thermo Scientific (Rockford, IL). SignalFire ECL Reagent, goat anti-rabbit secondary antibody, antipAKT Thr308 , and anti-pIRS1 Ser302 antibodies were from Cell Signaling Technology (Danvers, MA). Anti-FOXO3 and anti-GSTP1 antibodies were purchased from Millipore (Temecula, CA). Donkey anti-goat secondary antibody was purchased from Pierce Biotechnology (Rockford, IL). Anti-CYP2E1 antibody was purchased from Abcam (Cambridge, MA). Anti-mEH (EPHX1) antibody was purchased from Detroit R&D, Inc. (Detroit, M).
Animal procedures and tissue collection
All experimental animal protocols used in this study were approved by the Iowa State University Animal Care Committee. Four-weekold female normal wild-type nonagouti (a/a; designated lean; n = 20) and agouti lethal yellow (KK.Cg-Ay/J; designated obese; n = 20) mice were purchased from the Jackson Laboratory (Bar Harbor, [45] ), and fasting glucose levels from 12 weeks onwards [45] . Estrous cyclicity was also impacted by shorter time spent in estrus and longer time in diestrous [45] . In addition, primordial and small primary follicle numbers were decreased, while secondary and antral follicle numbers were increased in number with progressive obesity [45] . At the end of each experimental time point, mice were euthanized by CO 2 asphyxiation in the proestrus stage of the estrous cycle as determined by vaginal cytology. Ovaries were collected, cleaned of excess fat, and stored in RNAlater at -80
• C for RNA and protein analyses.
In vivo phosphoramide mustard exposure and tissue collection A separate group of normal wild-type nonagouti (a/a; designated lean; n = 10) and agouti lethal yellow (KK.Cg-Ay/J; designated obese; n = 10) mice aged 15 weeks were intraperitoneally (ip) dosed once with sesame oil or PM (95%; 25 mg/kg) (n = 5 per group). This dose was chosen based on the literature to cause primordial follicle loss, but not to completely eliminate the follicular pool [49] . Mice were euthanized 3 days after the end of dosing in their proestrus phase of the estrous cycle as determined by vaginal cytology. Ovary and lung tissue from each mouse was preserved in RNAlater at -80 • C for RNA and protein isolation.
RNA isolation, first-strand cDNA synthesis, and quantitative real-time polymerase chain reaction Total RNA was isolated from both lean and obese mice using Qiagen RNeasy Mini Kit (at 6, 12, 18, and 24 weeks, n = 3-4 per group per time point) as per the manufacturer's protocol [45] . Briefly, ovaries were lysed and homogenized using a hand-held homogenizer followed by applying the homogenate to a QIAshredder column with subsequent centrifugation at 16100 RCF for 2 min at room temperature. The resulting supernatant was applied to an RNeasy Mini column, allowing RNA to bind to the filter cartridge. Following washing, RNA was eluted from the filter and concentrated using an RNeasy MinElute Kit according to the manufacturer's protocol. The total RNA was eluted using 14 μL of RNase-free water and concentration determined using an ND-1000 Spectrophotometer (λ = 260/280 nm; NanoDrop technologies, Inc., Wilmington, DE). For cDNA synthesis, RNA (0. method. The results are presented as mean fold-change ± standard error relative to the lean-matched control group.
Protein isolation and western blot analysis
At each time point (6, 12, 18, or 24 weeks of age, n = 3-4 per group per time point), total ovarian protein was isolated and western blotting was performed as previously described [45] . Ovaries were homogenized in 300 μL of ice-cold tissue lysis buffer and protein concentration quantified using a standard bicinchoninic acid protocol on a 96-well assay plate. Equal total protein (20 μg) was separated on a 10%-12% SDS-PAGE and subsequently transferred to nitrocellulose membranes. Ponceau S staining was performed to visualize and confirm equal amount of protein loading and transfer. Following blocking for 2 h at room temperature, membranes were probed with specific primary antibodies [Rabbit Anti-GSTP1 HRP-conjugated secondary antibodies (1:10000 -1:20000) were added for 1 h at room temperature, and membrane-bound HRP was washed three consecutive times for 5 min each time in TTBS. Autoradiograms were visualized on X-ray film following 10-min incubation of membranes with 1X SignalFire ECL reagent. Densitometry of the appropriate sized bands was measured using Carestream Molecular Imaging software version 5.0 (Carestream Health Inc., Rochester, NY) which eliminates background noise. Densitometric values of appropriate target proteins were normalized to Ponceau S staining prior to statistical analysis.
Statistical analysis
Statistical analyses were performed using the unpaired t-test function of GraphPad Prism 5.5 software with a statistical significance level set at P < 0.05. A trend toward a biologically meaningful difference between treatments was considered if the P-value was less than 0.1. 
Results
Obesity increases ovarian mRNA expression of insulin signaling members
Since obese mice displayed reduced glucose clearance rate in addition to having higher fasting blood glucose levels [45] , we sought to determine the impact of progressive obesity on ovarian mRNA expression of insulin signaling members. At 6 weeks of age, ovaries from the obese mice had increased Insr ( Figure 1A , P < 0.05) and Irs3 ( Figure 1D , P < 0.01) but showed no difference in either Irs1 or Irs2 mRNA levels relative to ovaries from the lean mice. At 12 weeks, only Irs1 mRNA was increased ( Figure 1B , P < 0.001) with obesity but other members were not impacted by obesity. Similarly, ovaries from obese mice displayed increased Irs1 ( Figure 1B , P < 0.001) and Irs3 ( Figure 1D , P < 0.05) without significant effect on Insr ( Figure 1A ) and Irs2 ( Figure 1C ) mRNA levels at 18 weeks of age. In the 24-week-old group, obesity increased ovarian expression of Insr ( Figure 1A , P = 0.05), Irs1 ( Figure 1B , P < 0.0001), Irs2 ( Figure 1C , P < 0.01), and Irs3 ( Figure 1D , P < 0.01).
Progressive obesity increases ovarian phosphorylated insulin receptor substrate 1 protein
Following the impact of obesity on ovarian mRNA levels of insulin signaling members, we investigated protein levels of pIRS1 Ser302 (Figure 2) . Although there was no difference in phosphorylation of IRS1 protein at the serine 302 site at 6 weeks, relative to lean-matched controls, ovaries from obese mice showed a tendency for increased pIRS1 Ser302 protein levels at 12 weeks (P = 0.07), and increased protein at 18 (P < 0.05) and 24 (P < 0.01) weeks (Figure 2 ). Ovarian Kitlg/cKit-PI3K pathway members are elevated during obesity At 6 weeks, ovaries from the obese group had lower (P < 0.01) Kitlg ( Figure 3A ) and Foxo1 ( Figure 3E ) but not Kit, Akt1, Akt2, or Foxo3a mRNA levels than ovaries from lean females (Figure 3) . At 12 weeks, there was a marked increase in ovarian Kitlg ( Figure 1A , P < 0.05), Kit ( Figure 1B , P < 0.05), and Foxo1 ( Figure 1E , P < 0.0001) in obese compared to lean females, but there was no impact of obesity on Akt1 ( Figure 3C ), Akt2 ( Figure 3D ), or Foxo3a ( Figure 3F ) mRNA expression. Likewise, at 18 weeks, obesity did not affect ovarian Akt1 (Figure 3C ), Akt2 ( Figure 3D ), and Foxo1 ( Figure 3E ) mRNA levels, but increased Kitlg ( Figure 3A , P < 0.001), Kit ( Figure 3B , P < 0.0001), and Foxo3a ( Figure 3E , P < 0.01) mRNA levels. There was increased (P < 0.01) Kitlg, Kit, Akt1, Akt2, Foxo1, and Foxo3a mRNA levels in ovaries from obese compared to lean mice at 24 weeks ( Figure 3A-F) .
Ovarian phosphorylated AKT is increased by obesity without impacting FOXO3 protein levels
There were no differences in ovarian pAKT Thr308 protein levels between lean and obese females at 6 and 12 weeks, but obesity increased (P < 0.01) pAKT Thr308 protein expression at 18 and 24 weeks ( Figure 4A ). Total ovarian FOXO3A protein levels did not differ between lean and obese groups at any time points ( Figure 4B ).
Progressive obesity alters mRNA expression of ovarian xenobiotic metabolism genes Despite lack of a genotype effect on Gstm1, Gstp1, and Ephx1 mRNA levels at 6 weeks [50] , obesity increased (P < 0.001) ovarian Gstm1 ( Figure 5A ) and Ephx1 ( Figure 5C ) mRNA expression at 12, 18, and 24 weeks. On the contrary, ovarian Cyp2e1 mRNA expression was lower (P < 0.001) in the obese group at all of the time points investigated ( Figure 5D ). Gstp1 mRNA levels were decreased (P < 0.05) by obesity at 12 weeks; however, at 24 weeks there was a tendency (P = 0.06) for increased ovarian Gstp1 in obese versus lean females ( Figure 5B ). At 18 weeks, there was no difference between lean and obese females in ovarian Gstp1 mRNA levels ( Figure 5B ).
Abundance of ovarian xenobiotic metabolism proteins is impacted by increased body mass At 6 weeks, there was no difference in ovarian EPHX1, CYPE1, and GSTP1 protein levels between the two groups of mice ( Figure 6 ). Relative to their matched lean controls, obese females displayed a higher (P < 0.05) expression of ovarian GSTP1 at 18 and 24 weeks ( Figure 6A and C) . In a similar manner to the mRNA results, ovaries from obese mice had increased ovarian EPHX1 protein levels relative to their lean counterparts at 12 (P < 0.05), 18 (P < 0.01), and 24 (P < 0.0001) weeks ( Figure 6B and D) . Likewise, CYP2E1 protein expression was reduced in ovaries from obese females compared to their lean littermates at 12 (P < 0.01), 18 (P < 0.05), and 24 (P < 0.01) weeks ( Figure 6E and F).
Obesity alters ovarian EPHX1 in response to phosphoramide mustard exposure Lean mice exposed to PM had increased (P < 0.05) ovarian EPHX1 protein abundance ( Figure 7A ). Concurrent with our previous observations [50] , obese females had basally higher (P < 0.05) levels of ovarian EPHX1 relative to ovaries from lean mice. In contrast to ovaries from lean mice, the EPHX1 response to PM exposure was completely abrogated in obese mice ( Figure 7A ).
In lung tissue from lean and obese mice dosed with PM, there was increased EPHX1 protein abundance ( Figure 7B) ; however, the response in the obese mice tended toward significance (P < 0.1) while the response observed in the lean mice was greater (P < 0.05; Figure 7B ).
Discussion
Obese mothers have increased risk for miscarriage [51] , poor oocyte quality [52] , and birth defects in their offspring [51] . In a recent study, we discovered that ovaries from obese females may have Figure 6 . Abundance of ovarian xenobiotic metabolism proteins is impacted by increased body mass. Total ovarian protein was isolated from lean (L) and obese (O) mice at 6, 12, 18, or 12 weeks (n = 3-4 per group per time point). Protein expression was determined by western blotting, followed by densitometric quantification of the appropriate protein band using Carestream Molecular Imaging software. (A, C) GSTP1, (B, D) EPHX1, and (E, F) CYP2E1 protein levels. Bars represent means ± SEM in arbitrary units. Asterisk indicates significant difference from age-matched lean females at P < 0.05; dagger indicates P < 0.1.
increased susceptibility to environmental exposures due to increased levels of EPHX1 and altered GST levels [50] . Additionally, obese females had greater ovarian damage induced by the ovotoxicant 7,12-dimethylbenz[a]anthracene [50] . Although the mechanism(s) remain unclear, we propose that ovarian biotransformation capacity may be altered during obesity, leading to increased susceptibility to ovotoxicant effects. Additionally, in a study of progressive obesity, we demonstrated a reduction in preantral follicles in obese females [45] . Since roles for PI3K signaling in oocyte viability [53] , primordial follicle activation [54] [55] [56] [57] [58] [59] , and ovarian chemical metabolism [24, 25, 43] have been established, we also hypothesized that impacts on ovarian biotransformation capacity during obesity may be mediated through altered insulin-regulated PI3K signaling. Since our previous study investigated a single time point [50] , we chose a model of progressive obesity in which to determine impacts of obesity onset and establishment on the endpoints of interest.
Many rodent models of obesity have mutations in the satiety hormone leptin (ob/ob) [60] or its receptor (db/db) [61] . While these mutations result in rapid onset of obesity, they are rare in the human population [48, 62] . The lethal yellow mouse has a deletion mutation in the normal wild-type nonagouti (a/a) background which results in ectopic expression of agouti [46, 48, 63, 64] . Hypothalamic agouti overexpression inhibits the melanocyte stimulating hormone (MSH) receptor [65] leading to hyperphagia due to hindering of the inhibitory effects of feeding imparted by alpha-melanocyte-stimulating hormone (α-MSH) and cocaine-and amphetamine-regulated transcript [65, 66] . Subsequently, hyperphagia coupled with reduced energy expenditure results in the development of progressive obesity [46, 65] . Starting at 12 weeks of age, these mice are hyperinsulinemic [47] and hyperleptinemic [67] , and display insulin [46] and leptin [68] resistance. Additionally, premature reproductive failure is a common phenotype of the lethal yellow mouse [67, 69, 70] . Elevated insulin levels have been reported in both serum and follicular fluids of obese females [71, 72] . However, studies investigating whether the ovary retains insulin sensitivity during hyperinsulinemia are contradictory [36, 38, 39, 73] . We chose to perform evaluation of effects of obesity on ovarian PI3K and chemical metabolism signaling at 6, 12, 18, and 24 weeks of age, since these ages have been characterized in this model [47] and we have established the composition of the follicular pool at these same endpoints [45] .
Progressive obesity was associated with increased Irs1, Irs2, and Irs3 mRNA as well as pIRS1
Ser302 protein levels, perhaps indicating that ovarian insulin signaling pathway retains activity in ovaries from obese mice, supporting our previous data with both high fat diet-fed mice [36] and the lethal yellow mouse [45] . The IRS1 contains several tyrosine/serine phosphorylation sites that serve as docking sites for numerous downstream mediators of insulin growth-promoting and metabolic functions [74] [75] [76] [77] . Although most serine phosphorylations of IRS lead to insulin signaling attenuation [76] , phosphorylation of IRS1 at serine 302 in rodents, which corresponds to serine 307 of the human IRS1 [78, 79] , is associated with insulin stimulation and it is believed to have a positive action in subsequent IRS1 tyrosine phosphorylations [77] [78] [79] . In several studies, inhibition of pIRS1 Ser302 by glucose starvation or deprivation of short-term amino acid correlates with decreased IRS1 tyrosine phosphorylation and subsequent reduced insulin activity [76, 77, 80] . Also increased pIRS1 Ser302 has been observed during peripheral insulin resistance in the skeletal muscle of both rodents [81] and humans [82, 83] . Whether the observed increase in ovarian pIRS1 Ser302 protein levels during progressive obesity in this study represents positive or negative feedback to insulin stimulation is hard to discern, but provides further evidence that ovarian insulin signaling is sustained during obesity.
In cultured human ovarian cortex, insulin alone or in combination with IGF-I and IGF-II increased the percentage of primordial follicles transitioning to the primary stage [84] . In canines [85] and fetal hamster cultured ovaries [86] , elevated insulin concentrations activated preantral follicular growth and viability, while insulin also promoted the transition from primordial to primary follicle stage in rat ovaries [87] and bovine cortical pieces [88] . Moreover, insulin had an additive effect with Kit Ligand (KITLG) on increasing follicle activation in cultured neonatal rat ovaries [87, 89] . These studies suggest a functional role for insulin signaling in ovarian folliculogenesis regulation. Insulin acting through its receptor and the receptor substrate proteins can activate the PI3K-AKT-dependent signaling pathway [90] . AKT activation involves two phosphorylations: one at threonine 308 (Thr308) normally by phosphoinositide-dependent kinase (PDPK1) and the other at serine 473 (Ser473) by mammalian target of rapamycin complex 2 (mTORC2) [91] [92] [93] . In mouse liver [94] or skeletal muscle [95] lacking IRS1 or IRS2, AKT Thr308 phosphorylation (pAKT Thr308 ) is undetectable; however, AKT phosphorylation at Ser473 (pAKT Ser473 ) is retained [96] , thus pAKT Ser473 may not be the most sensitive indicator of IRS-mediated PI3K-AKT signaling [91, 97] . We demonstrate increased pAKT Thr308 with obesity progression indicating increased PI3K-AKT activation in obese females. FOXO3 is a downstream AKT target that is negatively regulated upon AKT activation [28, 92, 98, 99] . We noted a trend for a 60% and 70% reduction in this protein in ovaries from obese mice at 12 and 24 weeks, respectively, suggestive of increased activation of insulin-PI3K/AKT signaling pathway during progressive obesity. Hyperactivation of the PI3K-AKT-FOXO3 signaling pathway has been shown to increase the rate of primordial follicles activation and recruitment into the growing pool with eventual death of most of those follicles, leading to accelerated ovarian senescence [30, 57, 59, 100, 101] . In support of this posit, we previously demonstrated reduced follicle numbers due to obesity from 12 weeks onward in the lethal yellow mouse model [45] . In addition to insulin, PI3K-AKT-FOXO3a can be activated by KITLG through its protein-tyrosine kinase receptor, KIT [98, 102, 103] . Kit is expressed in the oocyte [104] [105] [106] , whereas Kitlg originates from the GC and TC [88, 107, 108] . In the ovary, KITLG binding to KIT induces phosphorylation of the regulatory subunit of PI3K and subsequent activation of AKT1 [98, 102, 103] . We previously found that that HFD-induced obesity increased Kitlg concomitant with increased Akt1 and decreased Foxo3a mRNA expression in murine ovaries [36] . In this study, we also observed increased ovarian Kit and Kitlg mRNA concomitant with increased pAKT Thr308 protein in obese mice relative to their lean littermates.
The ovarian KITLG-KIT pathway plays a pivotal role in regulation of ovarian folliculogenesis [107, [109] [110] [111] [112] [113] [114] and steroidogenesis [115] . In human ovarian follicles, blocking the KIT receptor using an anti-KIT antibody, ACK2, induced ovarian follicular atresia [116] . KITLG supplementation promoted the transition of primordial to the primary follicle stage in bovine ovarian cortical pieces [114] , and stimulated follicle activation in rodents [110, 112] . Taken together, our data support that activation of insulin-KITLG-KIT-AKT1 signaling pathway is induced by obesity, and this could be a potential mechanism underlying obesity-induced overactivation of primordial follicles into the growing follicular pool previously noted in both this mouse model [50] and rats [40] . In primary cultured rat hepatocytes, insulin administration decreased Cyp2e1 mRNA expression in a dose-dependent manner, and this was reversible by either addition of glucagon or PI3K inhibitors (Wortmannin or LY294002) [117, 118] . Increased Cyp2e1 mRNA and/or CYP2E1 protein abundance have been reported during diabetes [119] [120] [121] , glucagon treatment [117] , and starvation [120, 122] , physiological states that are normally associated with decreased insulin activity. Interestingly, EPHX1 expression pattern is opposite to CYP2E1 during these physiological states. Insulin treatment or refeeding increases Ephx1 mRNA, EPHX1 protein expression, and enzyme activity [122] [123] [124] ; however, diabetes [122, 124] , glucagon [123] , or starvation [122, 124] or PI3K inhibition [123] decreases Ephx1 expression. Similar to the liver, opposing expression patterns of ovarian EPHX1 and CYP2E1 expression have been previously reported [21, 36] . In this study, similar to the mRNA results, there was an increase in ovarian EPHX1 with a concomitant decrease in CYP2E1 protein levels in ovaries from obese females compared to their age-matched lean counterparts.
In a similar manner to EPHX1 and CYP2E1, the expression and activities of GST enzymes can be mediated through PI3K/AKT signaling [24, 125, 126] . In male rats, the addition of insulin reversed decreased hepatic GST activity that had been induced by diabetes [124] . Also, refeeding (associated with insulin stimulation) restored starvation-induced reduced liver GST enzyme activities [124] . We recently observed increased ovarian levels of Gstm1 mRNA, GSTM1 and GSTP1 proteins due to an obese phenotype [50] . In the data reported herein, we observed an increase in ovarian Gstm1 mRNA and GSTP1 protein expression with progressive obesity. GSTs are critical for detoxification of a number of xenobiotic compounds [24, 127, 128] . In addition, ovarian GSTP1 [15, 24] and GSTM1 [25] negatively regulate proapoptotic proteins; thus, their increased level in obesity may reflect a reduction in apoptosis during obesity. Both these functions are in agreement with GSTP1 and GSTM1 being implicated in susceptibility toward and poor prognosis from various forms of gynaecological tumours [125, 129, 130] and development of anticancer drug resistance [131] [132] [133] [134] [135] . Therefore, increased abundance of ovarian GSTM1 and GSTP1 during obesity could be part of the underlying mechanisms behind obesity-induced reproductive disorders in obese females.
In order to increase translatability of our findings to this point, we evaluated the impact of obesity on ovarian chemical biotransformation and challenged the lean and obese mice with PM, an ovotoxic metabolite of CPA. The single dose was based on an early study investigating ovotoxicity of PM [49] with our aim being to induce mild levels of follicle loss. Also, we had determined in another study that this PM dosage reduced ovarian weight in obese but not lean mice [136] . Additionally, both lean and obese mice had reduced primordial follicle number and DNA damage in response to PM. Interestingly, DNA repair was blunted in the obese female ovary in response to PM-induced DNA damage [136] . We have previously demonstrated that EPHX1 protein detoxifies PM [137] ; when EPHX1 was inhibited in cultured rat ovaries, greater PM-induced follicle loss was observed [137] , and thus the ovary responded to a single dose of PM exposure in terms of increased EPHX1. Thus, in this study, we evaluated whether obesity affected the ovarian EPHX1 response to PM exposure. Interestingly, comparison of the level of ovarian EPHX1 between obese and lean mice identified increased basal EPHX1 protein abundance in the obese mice. We had previously reported this finding in a separate experiment [50] , and these data further underscore that ovaries from obese females have altered potential for chemical biotransformation. Additionally, we discovered that, despite a higher basal EPHX1 level in ovaries from obese females, the response to PM exposure was essentially absent; thus, ovaries from obese females have the potential for reduced detoxification of the ovotoxicant PM during chemotherapy regimens that include CPA, thereby increasing ovarian damage that ensues. In order to further extend our findings, we investigated whether lung tissue was responsive to PM exposure. We have determined that PM can spontaneously transform into a volatile ovotoxicant [138] , and a study determined that a portion of administered CPA was expired from the lungs of treated animals as chloroethylaziridine [139] . We observed increased abundance of EPHX1 in the lungs of both lean and obese females and did not observe any notable difference due to obesity. Thus, these data could indicate that a volatile compound results from PM exposure in vivo and is an area for further exploration. Furthermore, the differences in EPHX1 response to PM between the lung and ovary underscore tissue-specific responses to chemical exposure.
Taken together, our data demonstrate that progressive obesity increased mRNA and/or protein of ovarian signaling pathways that regulate folliculogenesis and ovotoxicant metabolism. These findings are of concern since dysregulated activation of follicles into the growing pool will eventually result in their depletion, accelerating entry into ovarian senescence. In addition, altered ovarian capacity to biotransform chemicals could pose a threat to both folliculogenesis and stability of the germ line. It is noteworthy that the "lean" mice also experience increased body weight with aging; thus, the obesity-induced effects on ovarian physiology may be changes that occur with aging, but are happening at a more rapid rate. It would be of interest to determine if exercise of diet-induced weight loss could mitigate the obesity-induced ovarian effects and this is an area of interest for this group. We further demonstrated that the obese ovary has a compromised response in terms of EPHX1 induction in response to PM exposure which could translate into a worsened outcome for obese patients during anticancer therapies involving CPA.
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